Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Roberts

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cancers|June 19, 2024
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric PatientsRituraj Upadhyay, Brett Klamer, Jennifer Matsui, et al.
Cancer|March 17, 2020
An evolutionary framework for treating pediatric sarcomasDamon R Reed, Jonathan Metts, Mariyah Pressley, et al.
Molecular Cancer Therapeutics|December 19, 2019
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other SarcomasLong-Sheng Chang, Janet L Oblinger, Sarah S Burns, et al.
JCI Insight|August 24, 2018
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasisAmy C Gross, Hakan Cam, Doris A Phelps, et al.
Cancer Research|August 29, 2025
Metastasis-Initiating Osteosarcoma Subpopulations Establish Paracrine Interactions with Lung and Tumor Cells to Create a Metastatic NicheJames B Reinecke, Leyre Jimenez Garcia, Amanda J Saraf, et al.
The British Journal of Radiology|January 24, 2022
Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumorsSujith Baliga, Jennifer Matsui, Brett Klamer, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Integrative Single-cell and Spatial Transcriptomic Analysis of Osteosarcoma Reveals Conserved and Distinct Ecosystems Across Sites and SpeciesYogesh Budhathoki, Matthew V Cannon, Troy A McEachron, et al.
Iscience|July 19, 2021
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcomaMary Frances Wedekind, Katherine E Miller, Chun-Yu Chen, et al.
Molecular Therapy. Oncology|April 10, 2024
Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology SocietyTimothy P Cripe, Ryan D Roberts, Dawn S Chandler, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cancers|June 19, 2024
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric PatientsRituraj Upadhyay, Brett Klamer, Jennifer Matsui, et al.
Cancer|March 17, 2020
An evolutionary framework for treating pediatric sarcomasDamon R Reed, Jonathan Metts, Mariyah Pressley, et al.
Molecular Cancer Therapeutics|December 19, 2019
Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other SarcomasLong-Sheng Chang, Janet L Oblinger, Sarah S Burns, et al.
JCI Insight|August 24, 2018
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasisAmy C Gross, Hakan Cam, Doris A Phelps, et al.
Cancer Research|August 29, 2025
Metastasis-Initiating Osteosarcoma Subpopulations Establish Paracrine Interactions with Lung and Tumor Cells to Create a Metastatic NicheJames B Reinecke, Leyre Jimenez Garcia, Amanda J Saraf, et al.
The British Journal of Radiology|January 24, 2022
Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumorsSujith Baliga, Jennifer Matsui, Brett Klamer, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Integrative Single-cell and Spatial Transcriptomic Analysis of Osteosarcoma Reveals Conserved and Distinct Ecosystems Across Sites and SpeciesYogesh Budhathoki, Matthew V Cannon, Troy A McEachron, et al.
Iscience|July 19, 2021
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcomaMary Frances Wedekind, Katherine E Miller, Chun-Yu Chen, et al.
Molecular Therapy. Oncology|April 10, 2024
Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology SocietyTimothy P Cripe, Ryan D Roberts, Dawn S Chandler, et al.
Pageof 6